| Trial ID: | L2068 |
| Source ID: | NCT00231673
|
| Associated Drug: |
Topiramate
|
| Title: |
A Study To Evaluate The Effect Of Topiramate On Clinical And Electrophysiological Parameters In Subjects With Diabetic Peripheral Polyneuropathy
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetic Neuropathies|Diabetes Mellitus, Type 2|Polyneuropathies
|
| Interventions: |
DRUG: Topiramate
|
| Outcome Measures: |
Primary: Change in peroneal nerve conduction velocity (NCV) from baseline to the end of the double-blind phase. | Secondary: Changes from baseline to the end of the double-blind phase in NCVs of the sural sensory nerve and ulnar (motor and sensory) nerve, and changes in amplitudes and latencies of the peroneal motor, sural sensory, and ulnar nerves. Adverse event reporting.
|
| Sponsor/Collaborators: |
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
72
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2001-07
|
| Completion Date: |
2003-01
|
| Results First Posted: |
|
| Last Update Posted: |
2011-06-08
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00231673
|
